Connections between Cognitive Impairment and Atrial Fibrillation in Patients with Diabetes Mellitus Type 2

被引:8
|
作者
Militaru, Marius [1 ,2 ,3 ]
Lighezan, Daniel Florin [2 ,3 ,4 ]
Tudoran, Cristina [5 ,6 ,7 ]
Militaru, Anda Gabriela [2 ,3 ,4 ]
机构
[1] Univ Med & Pharm Victor Babes Timisoara, Dept 8, Pharm Victor Babes Timisoara, Discipline Neurol 2, E Murgu Sq 2, Timisoara 300041, Romania
[2] Municipal Emergency Hosp Timisoara, Clin Thorac Surg, Gheorghe Dima St 5, Timisoara 300254, Romania
[3] Univ Med & Pharm Victor Babes Timisoara, Ctr Adv Res Cardiol & Hemostasol, E Murgu Sq, 2, Timisoara 300041, Romania
[4] Univ Med & Pharm Victor Babes Timisoara, Dept 5, Discipline Med Semiol 1, E Murgu Sq, 2, Timisoara 300041, Romania
[5] Univ Med & Pharm Victor Babes Timisoara, Dept 7, Discipline Cardiol, E Murgu Sq 2, Timisoara 300041, Romania
[6] Univ Med & Pharm Victor Babes Timisoara, Ctr Mol Res Nephrol & Vasc Dis, E Murgu Sq 2, Timisoara 300041, Romania
[7] Cty Emergency Hosp Pius Brinzeu, L Rebreanu 156, Timisoara 300723, Romania
关键词
diabetes mellitus; atrial fibrillation; cognitive decline; dementia; subclinical atherosclerosis; memory tests; TRIGLYCERIDE GLUCOSE INDEX; ASSOCIATION; DEMENTIA; MORTALITY; DECLINE; DISEASE;
D O I
10.3390/biomedicines12030672
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
(1) Background: Cognitive decline (CD), considered a precursory state of dementia, is frequently encountered in patients with diabetes mellitus type 2 (DM-2) and might even have a higher prevalence in those with associated atrial fibrillation (AF). In this study, we aimed to research if the association of DM-2 and AF favors a precocious onset of CD. (2) Methods: This study was conducted on 160 patients, featuring 50 with DM-2, 54 with DM-2 and AF, and 56 subjects without DM-2 and AF, all evaluated clinically and with five neuropsychiatric scales. (3) Results: The Mini-Mental-State-Examination (MMSE), Montreal Cognitive Assessment (MoCA), Activities of Daily Living Score (ADL), Instrumental Activities of Daily Living Score (IADL), and Geriatric Depression Scale (GDS-15) were significantly altered in patients with DM-2 and AF in comparison to patients without these diseases. The logistic regression model indicated that, in patients with DM-2 and AF, an increase of one year in age is associated with a 7.3% augmentation of the risk of a precocious onset of CD (MMSE < 27). (4) Conclusions: CD is more frequent in patients with DM-2, especially when associated with AF, versus those without DM-2 and AF. Our findings suggest that an older age and associated dyslipidemia represent risk factors for CD in patients with DM-2.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] The association between blood lipids and cognitive impairment in type 2 diabetes mellitus
    Li Ma
    Yue-Xing Yuan
    Feng-Jin Cheng
    Yan Liu
    Qiong Wei
    You-Fan Peng
    Yao Wang
    European Journal of Medical Research, 29
  • [22] Factors for Cognitive Function Impairment in Elderly Patients with Type 2 Diabetes Mellitus Patients and Mild Cognitive Impairment (MCI)
    Xiao, L. J.
    Miao, H.
    Zhu, Q.
    Qian, Y.
    Wang, C. X.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 : S332 - S332
  • [23] The relationship between fatigue severity and mild cognitive impairment in Saudi patients with type 2 diabetes mellitus
    Bahgat, Fouad Fathy
    Fetyani, Ibrahim Majed
    Alnasser, Ali Hamad
    Alkhalaf, Abdulmohsen Mohammed
    Baqais, Mohammed Omar
    Habib, Syed Shahid
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2022, 72 (06) : 1255 - 1259
  • [24] The Clinical Phenotype of Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus
    Groeneveld, Onno N.
    Moneti, Costanza
    Heinen, Rutger
    de Bresser, Jeroen
    Kuijf, Hugo J.
    Exalto, Lieza G.
    Boomsma, Jooske M. F.
    Kappelle, L. Jaap
    Barkhof, Frederik
    Prins, Niels D.
    Scheltens, Philip
    van der Flier, Wiesje M.
    Biessels, Geert Jan
    Benedictus, M. R.
    Bremer, J.
    Goos, J.
    Leeuwis, A. E.
    Leijenaar, J.
    Tijms, B. M.
    Vrenken, H.
    Teunissen, C. E.
    van den Berg, E.
    Ferro, D. A.
    Frijns, C. J. M.
    Groeneveld, O. N.
    van Kalsbeek, N. M.
    Verwer, J. H.
    Koek, H. L.
    Boss, H. M.
    Weinstein, H. C.
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 68 (01) : 311 - 322
  • [25] Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus
    van Harten, Barbera
    Oosterman, Joukje
    Muslimovic, Dino
    van Loon, Bert-Jan Potter
    Scheltens, Philip
    Weinstein, Henry C.
    AGE AND AGEING, 2007, 36 (02) : 164 - 170
  • [26] Applicability of diagnostic constructs for cognitive impairment in patients with type 2 diabetes mellitus
    Groeneveld, Onno N.
    van den Berg, Esther
    Rutten, Guy E. H. M.
    Koekkoek, Paula S.
    Kappelle, L. Jaap
    Biessels, Geert Jan
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 142 : 92 - 99
  • [27] Type 2 diabetes mellitus and cognitive function: understanding the connections
    Dao, Lisa
    Choi, Sarah
    Freeby, Matthew
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2023, 30 (01) : 7 - 13
  • [28] Uncovering the Disease Progression Profile of the Patients with Type 2 Diabetes Mellitus and Atrial Fibrillation
    Tang, Zefang
    Wang, Jingjing
    Zhang, Yuan
    Hu, Pengwei
    Mei, Jing
    Li, Shoachun
    DIABETES, 2020, 69
  • [29] Serdang AF: Prescription patterns of atrial fibrillation patients with type 2 diabetes mellitus
    Hoo, Y. Y.
    Kepli, W. Mazlan
    Habizal, N. H.
    Ismail, M. I.
    Wong, Y. P.
    Rosnan, N. H.
    Mohamed, S.
    Abd Ghani, A. R.
    Yusof, H. Mohd
    Elias, N. A.
    Lee, K. C.
    Chanara, L.
    Theng, H. T.
    Gunaseelan, T. D. D.
    Teong, H. T.
    Ghapar, A. K. Abdul
    Ramaiah, A. R. Abdullah
    Selvaraj, K.
    Abd Malek, A. M.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 369 : 14 - 14
  • [30] ROLE OF GLYCEMIC CONTROL IN DEVELOPMENT OF ATRIAL FIBRILLATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Singhal, M.
    McAdam-Marx, C.
    LaFleur, J.
    Witt, D. M.
    Nelson, R. E.
    Biskupiak, J. E.
    VALUE IN HEALTH, 2016, 19 (03) : A10 - A10